|
1
|
Boyd C and Náray-Fejes-Tóth A:
Steroid-mediated regulation of the epithelial sodium channel
subunits in mammary epithelial cells. Endocrinology. 148:3958–3967.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gong H, Jarzynka MJ, Cole TJ, Le JH, Wada
T, Zhang B, Gao J, Song WC, DeFranco DB, Cheng SY and Xie W:
Glucocorticoids antagonize estrogens by glucocorticoid
receptor-mediated activation of estrogen sulfotransferase. Cancer
Res. 68:7386–7393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rachner TD, Benad P, Rauner M, Goettsch C,
Singh SK, Schoppet M and Hofbauer LC: Osteoprotegerin production by
breast cancer cells is suppressed by dexamethasone and confers
resistance against TRAIL-induced apoptosis. J Cell Biochem.
108:106–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buxant F, Kindt N, Laurent G, Noël JC and
Saussez S: Antiproliferative effect of dexamethasone in the MCF-7
breast cancer cell line. Mol Med Rep. 12:4051–4054. 2015.PubMed/NCBI
|
|
5
|
Machuca C, Mendoza-Milla C, Córdova E,
Mejía S, Covarrubias L, Ventura J and Zentella A: Dexamethasone
protection from TNF-alpha-induced cell death in MCF-7 cells
requires NF-kappaB and is independent from AKT. BMC Cell Biol.
7:92006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khan S, Lopez-Dee Z, Kumar R and Ling J:
Activation of NFkB is a novel mechanism of pro-survival activity of
glucocorticoids in breast cancer cells. Cancer Lett. 337:90–95.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Wang Y, Rayburn ER, Hill DL,
Rinehar JJ and Zhang R: Dexamethasone as a chemosensitizer for
breast cancer chemotherapy: Potentiation of the antitumor activity
of adriamycin, modulation of cytokine expression, and
pharmacokinetics. Int J Oncol. 30:947–953. 2007.PubMed/NCBI
|
|
8
|
Pang D, Kocherginsky M, Krausz T, Kim SY
and Conzen SD: Dexamethasone decreases xenograft response to
Paclitaxel through inhibition of tumor cell apoptosis. Cancer Biol
Ther. 5:933–940. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Honorat M, Mesnier A, Di Pietro A, Lin V,
Cohen P, Dumontet C and Payen L: Dexamethasone down-regulates ABCG2
expression levels in breast cancer cells. Biochem Biophys Res
Commun. 375:308–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Doyle LA, Yang W, Abruzzo LV, Krogmann T,
Gao Y, Rishi AK and Ross DD: A multidrug resistance transporter
from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA.
95:15665–15670. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JB, Ko E, Han W, Shin I, Park SY and
Noh DY: Berberine diminishes the side population and ABCG2
transporter expression in MCF-7 breast cancer cells. Planta Med.
74:1693–1700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24(−/low)/CD44+ breast cancer-initiating cells to
radiation. J Natl Cancer Inst. 98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Y, He Z, Zhu H, Chen X, Li J, Zhang H,
Pan X and Hu Y: Murine fertilized ovum, blastomere and morula cells
lacking SP phenotype. Sci China C Life Sci. 50:762–765. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scharenberg CW, Harkey MA and Torok-Storb
B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump
and is preferentially expressed by immature human hematopoietic
progenitors. Blood. 99:507–512. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dieterlen-Lièvre F: Lineage-switching by
pluripotent cells derived from adults. J Soc Biol. 195:39–46.
2001.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burkert J, Otto W and Wright N: Side
populations of gastrointestinal cancers are not enriched in stem
cells. J Pathol. 214:564–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Y, Kitisin K, Jogunoori W, Li C, Deng
CX, Mueller SC, Ressom HW, Rashid A, He AR, Mendelson JS, et al:
Progenitor/stem cells give rise to liver cancer due to aberrant
TGF-beta and IL-6 signaling. Proc Natl Acad Sci USA. 105:2445–2450.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin L, Castagnino P and Assoian RK: ABCG2
expression and side population abundance regulated by a
transforming growth factor beta-directed epithelial-mesenchymal
transition. Cancer Res. 68:800–807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheridan C, Kishimoto H, Fuchs RK,
Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet J Jr, Badve S and
Nakshatri H: CD44+/CD24- breast cancer cells exhibit enhanced
invasive properties: An early step necessary for metastasis. Breast
Cancer Res. 8:R592006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pavek P, Merino G, Wagenaar E, Bolscher E,
Novotna M, Jonker JW and Schinkel AH: Human breast cancer
resistance protein: Interactions with steroid drugs, hormones, the
dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine,
and transport of cimetidine. J Pharmacol Exp Ther. 312:144–152.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elahian F, Kalalinia F and Behravan J:
Dexamethasone downregulates BCRP mRNA and protein expression in
breast cancer cell lines. Oncol Res. 18:9–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elahian F, Kalalinia F and Behravan J:
Evaluation of indomethacin and dexamethasone effects on
BCRP-mediated drug resistance in MCF-7 parental and resistant cell
lines. Drug Chem Toxicol. 33:113–119. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujii Y and Nakayama M: Reduction of
postoperative nausea and vomiting and analgesic requirement with
dexamethasone in women undergoing general anesthesia for
mastectomy. Breast J. 13:564–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Igarashi H, Medina KL, Yokota T, Rossi MI,
Sakaguchi N, Comp PC and Kincade PW: Early lymphoid progenitors in
mouse and man are highly sensitive to glucocorticoids. Int Immunol.
17:501–511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Srivastava AS, Kaushal S, Mishra R, Lane
TA and Carrier E: Dexamethasone facilitates erythropoiesis in
murine embryonic stem cells differentiating into hematopoietic
cells in vitro. Biochem Biophys Res Commun. 346:508–516. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi YH, Ko SH, Kim SJ, Lee WY, Park JH
and Lee JM: Induction of cell death by photodynamic therapy with a
new synthetic photosensitizer DH-I-180-3 in undifferentiated and
differentiated 3T3-L1 cells. Biochem Biophys Res Commun.
337:1059–1064. 2004. View Article : Google Scholar
|
|
29
|
Hussein MA, Bolejack V, Zonder JA, Durie
BG, Jakubowiak AJ, Crowley JJ and Barlogie B: Phase II study of
thalidomide plus dexamethasone induction followed by tandem
melphalan-based autotransplantation and thalidomide-plus-prednisone
maintenance for untreated multiple myeloma: A southwest oncology
group trial (S0204). J Clin Oncol. 27:3510–3517. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahmed S, Johnson CS, Reuger RM and Trump
DL: Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity
of mitoxantrone/dexamethasone in an androgen independent prostate
cancer model. J Urol. 168:756–761. 2002. View Article : Google Scholar : PubMed/NCBI
|
